OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Yi Ju, Wen Shi Lee, Emily H. Pilkington, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 11769-11780
Open Access | Times Cited: 195
Yi Ju, Wen Shi Lee, Emily H. Pilkington, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 11769-11780
Open Access | Times Cited: 195
Showing 1-25 of 195 citing articles:
Innate immune mechanisms of mRNA vaccines
R Verbeke, Michael J. Hogan, Karin Loré, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 215
R Verbeke, Michael J. Hogan, Karin Loré, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 215
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
Yan Zong, Yi Lin, Tuo Wei, et al.
Advanced Materials (2023) Vol. 35, Iss. 51
Closed Access | Times Cited: 161
Yan Zong, Yi Lin, Tuo Wei, et al.
Advanced Materials (2023) Vol. 35, Iss. 51
Closed Access | Times Cited: 161
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 112
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 112
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 108
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 108
Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
Yi Ju, Juan Manuel Carreño, Viviana Simon, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 135-136
Open Access | Times Cited: 107
Yi Ju, Juan Manuel Carreño, Viviana Simon, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 135-136
Open Access | Times Cited: 107
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
Bioconjugate Chemistry (2023) Vol. 34, Iss. 6, pp. 941-960
Open Access | Times Cited: 87
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
Bioconjugate Chemistry (2023) Vol. 34, Iss. 6, pp. 941-960
Open Access | Times Cited: 87
Engineering Poly(ethylene glycol) Nanoparticles for Accelerated Blood Clearance Inhibition and Targeted Drug Delivery
Yuan Tian, Zhiliang Gao, Ning Wang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 40, pp. 18419-18428
Closed Access | Times Cited: 82
Yuan Tian, Zhiliang Gao, Ning Wang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 40, pp. 18419-18428
Closed Access | Times Cited: 82
Yongsheng Gao, Maithili Joshi, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Controlling the biodistribution and clearance of nanomedicines
Horacio Cabral, Junjie Li, Kanjiro Miyata, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 3, pp. 214-232
Closed Access | Times Cited: 67
Horacio Cabral, Junjie Li, Kanjiro Miyata, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 3, pp. 214-232
Closed Access | Times Cited: 67
Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
K. Swetha, Niranjan G. Kotla, Lakshmi Tunki, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 658-658
Open Access | Times Cited: 58
K. Swetha, Niranjan G. Kotla, Lakshmi Tunki, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 658-658
Open Access | Times Cited: 58
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 50
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 50
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4561-4570
Open Access | Times Cited: 45
Gergely Tibor Kozma, Tamás Mészáros, Petra Berényi, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4561-4570
Open Access | Times Cited: 45
Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)
Yaelle Bavli, Bing‐Mae Chen, Guy Gross, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 316-322
Open Access | Times Cited: 43
Yaelle Bavli, Bing‐Mae Chen, Guy Gross, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 316-322
Open Access | Times Cited: 43
Anti-PEG antibodies: Current situation and countermeasures
Jiaru Fu, Ercan Wu, Guanghui Li, et al.
Nano Today (2024) Vol. 55, pp. 102163-102163
Closed Access | Times Cited: 20
Jiaru Fu, Ercan Wu, Guanghui Li, et al.
Nano Today (2024) Vol. 55, pp. 102163-102163
Closed Access | Times Cited: 20
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
Mariona Estapé Sentí, Lucía García del Valle, Raymond M. Schiffelers
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115190-115190
Open Access | Times Cited: 19
Mariona Estapé Sentí, Lucía García del Valle, Raymond M. Schiffelers
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115190-115190
Open Access | Times Cited: 19
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions
Thomas J. Anchordoquy, Natalie Artzi, Irina V. Balyasnikova, et al.
ACS Nano (2024) Vol. 18, Iss. 22, pp. 13983-13999
Closed Access | Times Cited: 18
Thomas J. Anchordoquy, Natalie Artzi, Irina V. Balyasnikova, et al.
ACS Nano (2024) Vol. 18, Iss. 22, pp. 13983-13999
Closed Access | Times Cited: 18
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 16
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 16
Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 15
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 15
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
Matthew N. O’Brien, David A. Foley, Roger H. Pak, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
Matthew N. O’Brien, David A. Foley, Roger H. Pak, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 2
High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics
Yufen Xiao, Xizhen Lian, Yehui Sun, et al.
Nature Materials (2025)
Closed Access | Times Cited: 1
Yufen Xiao, Xizhen Lian, Yehui Sun, et al.
Nature Materials (2025)
Closed Access | Times Cited: 1
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
Juan Manuel Carreño, Gagandeep Singh, Johnstone Tcheou, et al.
Vaccine (2022) Vol. 40, Iss. 42, pp. 6114-6124
Open Access | Times Cited: 65
Juan Manuel Carreño, Gagandeep Singh, Johnstone Tcheou, et al.
Vaccine (2022) Vol. 40, Iss. 42, pp. 6114-6124
Open Access | Times Cited: 65
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration
Giuditta Guerrini, Sabrina Gioria, Aisha V. Sauer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8838-8838
Open Access | Times Cited: 52
Giuditta Guerrini, Sabrina Gioria, Aisha V. Sauer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8838-8838
Open Access | Times Cited: 52
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Zhongfeng Ye, Joseph F. Harmon, Wei Ni, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15231-15253
Closed Access | Times Cited: 36
Zhongfeng Ye, Joseph F. Harmon, Wei Ni, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15231-15253
Closed Access | Times Cited: 36
